Opioid-induced Constipation

• FDA label_change · 2019-05-29
  FDA Approved: MOVANTIK — Supplemental Application (RedHill Biopharma Ltd)

  FDA approved a supplemental application for MOVANTIK (naloxegol oxalate) submitted by RedHill Biopharma Ltd, primarily affecting labeling ch…

• FDA label_change · 2018-03-14
  FDA Approved: RELISTOR — Supplemental Application (Salix Pharmaceuticals, Inc.)

  The FDA approved a supplemental application for Relistor (methylnaltrexone bromide) from Salix Pharmaceuticals to update its labeling.